Morning Overview on MSN
New AI model could radically change genetic testing and drug discovery
A new generation of artificial intelligence is starting to read the human genome with a fluency that would have sounded like ...
The MarketWatch News Department was not involved in the creation of this content. REDWOOD CITY, Calif., Oct. 28, 2025 /PRNewswire/ -- Today, the Chan Zuckerberg Initiative (CZI) and NVIDIA announced ...
Illumina’s Billion Cell Atlas aims to standardize massive CRISPR perturbation data to make biological response patterns more ...
Phenotypic 3D cell models incorporate tissue architectures and extracellular matrices to recapitulate the complexity of the ...
Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, today announced the results of a new study detailing an ...
Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.
Ginkgo Bioworks has announced the launch of the Virtual Cell Pharmacology Initiative (VCPI) through Ginkgo Datapoints. This open-source platform is designed to build a standardized framework for ...
News Medical on MSN
Cells can generate negative viscosity to propel movement
The cells in our bodies move in groups during biological processes such as wound healing and tissue development - but because ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results